Category: News
-
Meet the New BG Lab Virtual Cancer Groundshot Fellow: Dr. Javier-David Benítez-Fuentes
March 11, 2026. BG Lab is excited to announce our second BG Lab Virtual Cancer Groundshot Fellow, Dr. Javier-David Benítez-Fuentes. Dr. Javier-David Benítez-Fuentes is a consultant medical oncologist at Hospital General Universitario de Elche in Spain, specialised in thoracic malignancies. He completed his medical oncology training at Hospital Clínico San Carlos in Madrid, followed by a…
-
Dr. Bishal Gyawali Leads the New ASCO Guidelines on use of WBC Growth Factors
March 1, 2026. Dr. Gyawali is the first author and a co-chair for the newly published ASCO Guidelines on the use of white blood cell (WBC) colony stimulating factors in patients with cancer receiving systemic treatment. These guidelines were published in the Journal of Clinical Oncology. These updated guidelines help shared decision making among patients,…
-
Meet the First General Practitioner in Oncology Fellow of Nepal: Dr. Bishrut Sapkota
February 23, 2026. This January, we enrolled our first GPO fellow in Nepal, Dr. Bishrut Sapkota. In this story, we get to know more about the GPO fellowship program and Dr. Sapkota. One of the main global oncology focuses of BG Lab has been Nepal, given the roots of our PI Dr. Bishal Gyawali, who…
-
Meet the First BG Lab Cancer Groundshot Virtual Fellow: Dr. Syeda Mina
January 23, 2026. Today, BG Lab is excited to announce our first BG Lab Cancer Groundshot Fellow, Dr. Syeda Mina. Dr. Mina is a hematology and medical oncology fellow at Mayo Clinic in Rochester, Minnesota and will be graduating in July. She completed her medical training at Alfaisal University in Saudi Arabia, and her internal…
-
BG Lab Released Their 2025 Annual Report
BG Lab released their first annual report for the 2025 year! We had an amazing year full of mentoring, forming connections with experts across the globe, welcoming new trainees, and celebrating trainee milestones. This year was very productive for us – we produced 27 peer-reviewed publications, delivered 24 presentations, and our PI Dr. Bishal Gyawali…
-
Dr. Bishal Gyawali Honoured as Highly Ranked Scholar by ScholarGPS
ScholarGPS recognized Dr. Gyawali as a Highly Ranked Scholar in the specialties of Global Oncology and Progression-Free Survival. Highly Ranked Scholar is based on a quantitative assessment and recognizes scholars for their exceptional productivity, impact, and quality of scholarly contributions that have placed them in the top 0.05% of scholars worldwide. Dr. Gyawali was ranked…
-
A Case for Superiority Design De-Escalation Trials
Dr. Gyawali recently published a thought-provoking article in JNCI making a compelling case for using superiority design rather than noninferiority design to test de-escalation strategies in cancer care. Graphical abstract by Laure-Anne Teuwen Overtreatment is a growing concern in cancer care, where patients who may not benefit are being treated, or treatment may begin earlier,…
-
Beyond the Hype: Lessons From ESMO 2025 Oncology Trial Data – New Medscape Skills Lab Video
Dr. Gyawali previously released a Medscape video discussing key learning lessons from the ESMO 2025 annual meeting – watch it here! He continues this discussion in a new Medscape video focusing on prognostic and predictive markers, as it was frequently touched on during the ESMO 2025 meeting. Using examples from trials presented at ESMO 2025,…
-
ESMO 2025: Cutting Through the Hype With Real Data and Real Math – New Medscape Skills Lab Video
Dr. Gyawali returned a Skills Lab video discussing the key learning lessons from the ESMO 2025 annual meeting. You can watch the video or read the transcript now on Medscape. He talks about the need for greater critical analysis of the trial results that are being presented at ESMO. He also encourages audience members to…
-
SCRI Celebrated Dr. Bishal Gyawali’s Award for Excellence in Cancer Research
On December 4, 2025, Queen’s SCRI hosted a ceremony to celebrate Dr. Gyawali’s receipt of the 2024 Canadian Cancer Society Award for Excellence in Cancer Research. Dr. Gyawali received the William E. Rawls Prize as an early-career researcher for his significant and important advancements in cancer control research, which we discussed in a previous news…
